Radiation-induced xerostomia: Pathophysiology, clinical course and supportive treatment

Supportive Care in Cancer

Volumn 5, Issue 4, 1997, Pages 281-288

  Guchelaar, H J ^a   Vermes, A ^a   Meerwaldt, J H ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Ionizing radiation; Moistening agents; Saliva substitutes; Sialogogues; Xerostomia

Indexed keywords

ANETHOLE TRITHIONE; BROMHEXINE; CARBACHOL; CARBOXYMETHYLCELLULOSE; NEOSTIGMINE; NICOTINIC ACID; PILOCARPINE; POTASSIUM BROMATE; SALIVA SUBSTITUTE; SORBITOL; XYLITOL;

CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; IONIZING RADIATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SALIVATION; XEROSTOMIA;

HEAD AND NECK NEOPLASMS; HUMANS; PALLIATIVE CARE; RADIATION INJURIES; RADIOTHERAPY; SALIVA, ARTIFICIAL; SALIVARY GLANDS; SALIVATION; XEROSTOMIA;

EID: 0030790683     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050075     Document Type: Review

References (57)

1. Atkinson JC, Fox PC (1992) Salivary gland dysfunction. Clin Geriatr Med 8:499-511
2. Beumer J, Curtis T, Harrison RE (1979) Radiation therapy of the oral cavity: sequelae and management, part 1. Head Neck Surg 1: 301-312
3. Brundage S (1989) Use of lozenges may cause dry mouth. Postgrad Med 85:35
4. Bump EA, Brown JM (1990) Role of glutathione in the radiation response of mammalian cells in vitro and in vivo. Pharmacol Ther 47:117-136
5. Busuttil A (1977) Irradiation-induced changes in human salivary glands. Clin Otolaryngol 2: 199-206
6. Chencharick JD, Mossman KL (1983) Nutritional consequences of the radiotherapy of head and neck cancer. Cancer 51:811-815
7. Cohen JJ (1993) Apoptosis. Immunol Today 14:126-130
8. Cowman RA, Baron SS, Glassman AH, Davis ME, Strosberg AM (1983) Changes in protein composition of saliva from radiation-induced xerostomia patients and its effect on growth of oral streptococci. J Dent Res 62:336-340
9. D'Amico AV, McKenna WG (1994) Apoptosis and a re-investigation of the biologic basis for cancer therapy. Radiother Oncol 33:3-10
10. Davies AN, Singer J (1994) A comparison of artificial saliva and pilocarpine in radiation-induced xerostomia. J Laryngol Otol 108:663-665
11. Delic J, Mamdelénat H, Barbaroux C, Chaillet M-P, Dubray B, Gluckman E, Fourquet A, Girinski T, Cosset J-M (1995) In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation. Br J Radiol 68:997-1003
12. Dreizen S, Brown LR, Daly TE, Drane JB (1977) Prevention of xerostomia-related dental caries in irradiated cancer patients. J Dent Res 56:99-104
13. Eneroth CM, Henrikson CO, Jacobsson PA (1972) Effect of fractionated radiotherapy on salivary gland function. Cancer 30:1147-1153
14. Epstein JB, Schubert MM (1987) Synergistic effect of sialogogues in management of xerostomia after radiation therapy. Oral Surg Oral Med Oral Pathol 64:179-182
15. Epstein JB, Decoteau WE, Wilkinson A (1983) Effect of Sialor in treatment of xerostomia in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 56:495-499
16. Fox PC (1987) Systemic therapy of salivary gland hypofunction. J Dent Res 66:689-692
17. Fox PC, Ven PF van der, Baum BJ, Mandel D (1986) Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 61:243-248
18. Fox PC, Atkinson JC, Macynski AA, Wolf A, Kung DS, Valdez IH, Jackson W, Delapenha RA, Shiroky J, Baum BJ (1991) Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 151:1149-1152
19. Frank RM, Herdly J, Philippe E (1965) Acquired dental defects and salivary gland lesions after irradiation for carcinoma. J Am Dent Assoc 70:868-883
20. Gazda MJ, Schultheiss TE, Stephens LC, Ang KK, Peters LJ (1992) The relationship between apoptosis and atrophy in the irradiated lacrimal gland. Int J Radiat Oncol Biol Phys 24:693-697
21. Greenspan D (1990) Managment of salivary dysfunction. NCI Monogr 9:159-161
22. Greenspan D, Daniels TE (1987) Effectiveness of pilocarpine in postradiation xerostomia. Cancer 59:1123-1125
23. Helm JF (1989) Role of saliva in esophageal health and disease. Dysphagia 4:76-84
24. Hughes CV, Baum BJ, Fox PC, Marmary Y, Yen CK, Sonnies BC (1987) Oral-pharyngeal dysphagia: a common sequelae of salivary gland dysfunction. Dysphagia 1:173-177
25. Hunt TL (1991) The effect of a high fat meal on the biovailability of oral pilocarpine hydrochloride (HCI) in healthy male subjects. MGI Pharma (Minneapolis) data on file. MGI 647.83CR91-02
26. Hunt TL (1991) A double blind, placebo-controlled, multiple dose tolerance and pharmacokinetic study of oral pilocarpine hydrochloride (HCl) in healthy male subjects. MGI Pharma (Minneapolis) data on file. MGI 647.83CR91-03
27. Izutsu KT, Truelove EL, Bleyer WA, Anderson WM, Schubert MM, Rice JC (1981) Whole saliva albumin as an indicator of stomatitis in cancer therapy patients. Cancer 48:1450-1454
28. Jansma J (1991) Oral sequelae resulting from head and neck radiotherapy. PhD thesis, University of Groningen, The Netherlands
29. Joensuu H, Bostrom P, Makkonen T (1993) Pilocarpine and carbacholine in treatment of radiation-induced xerostomia. Radiother Oncol 26:33-37
30. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, Muscoplat CC, Gallagher SC (1993) Oral pilocarpine for post-radiation xerostomia in patients with head and neck cancer. N Engl J Med 329:390-395
31. Kerr J, Wyllie A, Currie G (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
32. Korsten MA, Rosman AS, Fishbein S, Shlein RD, Goldberg HE, Biener A (1991) Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 90:701-706
33. Kusler DL, Rambur BA (1992) Treatment for radiation-induced xerostomia. Cancer Nurs 15:191-195
34. Langley RE, Palayoor ST, Coleman N, Bump CN (1993) Modifiers of radiation-induced apoptosis. Radiat Res 6:320-326
35. LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, Gallagher SC, Muscoplat SC (1993) A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 11:1124-1131
36. Levine MJ, Aguirre A, Hatton MN, Tabak LA (1987) Artificial salivas: present and future. J Dent Res 66:693-698
37. Ling CC, Chen CH, Li WX (1994) Apoptosis induced at different dose rates: implication for the shoulder region of cell survival curves. Radiother Oncol 32:129-136
38. Marks JE, Davis CC, Gottsman VL, Purdy JE, Lee F (1981) The effects of radiation on parotid salivary function. Int J Radiat Oncol Biol Phys 7:1013-1019
39. Mira JG, Wescott WB, Starcke EN, Shannon IL (1981) Some factors influencing salivary function when treating with radiotherapy. Int J Radiat Oncol Biol Phys 7:535-541
40. Mossman KL, Shatzman AL, Chencharick JD (1981) Effects of radiotherapy on human parotid saliva. Radiat Res 88: 403-412
41. Mossman K, Shatzman A, Chencharick J (1982) Long-term effects of radiotherapy on taste and salivary function in man. Im J Radiat Oncol Biol Phys 8:991-997
42. Radford IR (1985) The level of induced DNA double-strand breakage correlates with cell killing after X-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med 48:45-54
43. Rhodus N, Brown J (1990) The association of xerostomia and inadequate intake m older adults. J Am Diet Assoc 90:1688-1692
44. Rieke JW, Hafermann MD, Johnson JT, LeVeque FG, Iwamoto R, Steiger BW, Muscoplat C, Gallagher SC (1995) Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 31:661-669
45. Schneyer LH, Schneyer CA (1967) Inorganic composition of saliva. In: Code CF (ed) Handbook of alimentary canal, vol II. American Physiological Society, Washington, pp 497-530
46. Shannon IL, McCrary BR, Starcke EN (1977) A saliva substitute for use by xerostomic patients undergoing radiotherapy to the head and neck. Oral Surg Oral Med Oral Pathol 44:656-661
47. Shannon IL, Trodahl JN, Starcke EN (1978) Radiosensitivity of the human parotid gland. Proc Soc Exp Biol Med 157:50-53
48. Stephens LC, King GK, Peters LJ (1986) Acute and late radiation injury in rhesus monkey parotid glands. Am J Pathol 124:469-478
49. Tsujii H (1985) Quantitative dose-response analysis of salivary function following radiotherapy using sequential RI-sialography. Int J Radiat Oncol Biol Phys 11:1603-1612
50. Valdez IH (1991) Radiation-induced salivary dysfunction: clinical course and significance. Spec Care Dent 11:252-255
51. Valdez HI, Wolff A, Atkinson JC, Macynski AA, Fox PC (1993) Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 71:1848-1851
52. Vermes I, Haanen C (1994) Apoptosis and programmed cell death in health and Disease. Adv Clin Chem 31:177-246
53. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39-51
54. Vissink A, Panders AK, 's-Gravenmade EJ, Vermey A (1988) The causes and consequences of hyposalivation. Ear Nose Throat J 67:166-176
55. Wescott WB, Mira JG, Starcke EN, Shannon IL, Thornby JI (1978) Alterations in whole saliva flow rate induced by fractionated radiotherapy. AJR Am J Roentgenol 130:145-149
56. Westin T, Jansson A, Zenckert C, Hallstrom T, Edstrom S (1988) Mental depression is associated with malnutrition in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 114:1449-1453
57. Wiseman LS, Faulds D (1995) Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs 49:143-155